{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:47:34Z","timestamp":1775749654686,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jogoh.2020.101702","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T11:22:51Z","timestamp":1580556171000},"page":"101702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Equivalent live-birth rate in antagonist IVF\/ICSI protocol after oocyte triggering with GnRH agonist supplemented with 1500 r-hCG the day of oocyte retrieval vs r-hCG : A case-control study"],"prefix":"10.1016","volume":"49","author":[{"given":"Faustine","family":"Cherri\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Arvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Le Pabic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Bidet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Jaffr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Guivarc'h-Lev\u00eaque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2020.101702_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101702_bib0010","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jogoh.2020.101702_bib0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0030-1265678","article-title":"Ovarian hyperstimulation syndrome prevention strategies: luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger","volume":"28","author":"Engmann","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.jogoh.2020.101702_bib0020","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jogoh.2020.101702_bib0025","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"Griesinger","year":"2011","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.jogoh.2020.101702_bib0030","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2020.101702_bib0035","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jogoh.2020.101702_bib0040","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/humrep\/der333","article-title":"Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates","volume":"26","author":"Radesic","year":"2011","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jogoh.2020.101702_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.fertnstert.2011.12.010","article-title":"Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos","volume":"97","author":"Garcia-Velasco","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101702_bib0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.fertnstert.2011.12.020","article-title":"Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support","volume":"97","author":"Engmann","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101702_bib0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101702_bib0060","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","article-title":"Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG","volume":"28","author":"Seyban","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101702_bib0065","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","article-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u201cfreeze-all\u201d approach in GnRH antagonist protocol","volume":"101","author":"Fatemi","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101702_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149615","article-title":"Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol","volume":"11","author":"Griesinger","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jogoh.2020.101702_bib0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101702_bib0080","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.fertnstert.2011.07.1138","article-title":"Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?","volume":"96","author":"Guivarc\u2019h-Lev\u00eaque","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101702_bib0085","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101702_bib0090","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jogoh.2020.101702_bib0095","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","article-title":"Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study","volume":"28","author":"Iliodromiti","year":"2013","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jogoh.2020.101702_bib0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/humrep\/dey054","article-title":"Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial","volume":"33","author":"Elgindy","year":"2018","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jogoh.2020.101702_bib0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2017.00116","article-title":"GnRH agonist trigger and LH activity luteal phase support versus hCG trigger and conventional luteal phase support in fresh embryo transfer IVF\/ICSI Cycles-A systematic PRISMA review and meta-analysis","volume":"8","author":"Haahr","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jogoh.2020.101702_bib0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/humrep\/dev339","article-title":"A fresh look at the freeze-all protocol: a SWOT analysis","volume":"31","author":"Blockeel","year":"2016","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jogoh.2020.101702_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJMoa1705334","article-title":"Transfer of fresh versus frozen embryos in ovulatory women","volume":"378","author":"Shi","year":"2018","journal-title":"N Engl J Med"},{"issue":"378","key":"10.1016\/j.jogoh.2020.101702_bib0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa1703768","article-title":"IVF transfer of fresh or frozen embryos in women without polycystic ovaries","volume":"11","author":"Vuong","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2020.101702_bib0125","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2018.05.024","article-title":"Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry","volume":"110","author":"Acharya","year":"2018","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.jogoh.2020.101702_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176600","article-title":"Individual luteolysis pattern after GnRH-agonist trigger for final oocyte maturation","volume":"12","author":"Lawrenz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jogoh.2020.101702_bib0135","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-016-0764-7","article-title":"Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience","volume":"33","author":"Andersen","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jogoh.2020.101702_bib0140","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/727569","article-title":"Contribution to more patient-friendly ART treatment: efficacy of continuous low-dose GnRH agonist as the only luteal support-results of a prospective, randomized, comparative study","volume":"2015","author":"Pirard","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jogoh.2020.101702_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.10.011","article-title":"Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles","volume":"107","author":"Bar Hava","year":"2017","journal-title":"Fertil Steril"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720300295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720300295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:56:13Z","timestamp":1762854973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784720300295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2468784720300295"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101702","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equivalent live-birth rate in antagonist IVF\/ICSI protocol after oocyte triggering with GnRH agonist supplemented with 1500 r-hCG the day of oocyte retrieval vs r-hCG : A case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101702"}}